| 25.24 0.55 (2.23%) | 01-16 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 29.67  |
1-year : | 34.65 |
| Resists | First : | 25.4 |
Second : | 29.67 |
| Pivot price | 23.05 |
|||
| Supports | First : | 23.01 |
Second : | 21.53 |
| MAs | MA(5) : | 24.14 |
MA(20) : | 22.83 |
| MA(100) : | 20.93 |
MA(250) : | 19.68 |
|
| MACD | MACD : | 0.8 |
Signal : | 0.6 |
| %K %D | K(14,3) : | 96.4 |
D(3) : | 88.3 |
| RSI | RSI(14): 77.1 |
|||
| 52-week | High : | 25.4 | Low : | 14.22 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ NVST ] has closed above the upper band by 0.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 124.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 25.44 - 25.55 | 25.55 - 25.65 |
| Low: | 24.38 - 24.49 | 24.49 - 24.59 |
| Close: | 25.07 - 25.25 | 25.25 - 25.44 |
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Sat, 17 Jan 2026
Envista Holdings (NVST) Receives a Buy from Bank of America Securities - The Globe and Mail
Wed, 14 Jan 2026
Envista Holdings Corp stock hits 52-week high at $23.97 - Investing.com
Fri, 09 Jan 2026
Improved Revenues Required Before Envista Holdings Corporation (NYSE:NVST) Shares Find Their Feet - simplywall.st
Fri, 09 Jan 2026
Improved Revenues Required Before Envista Holdings Corporation (NYSE:NVST) Shares Find Their Feet - Sahm
Thu, 08 Jan 2026
Envista Schedules Fourth Quarter 2025 Earnings Call - Nasdaq
Wed, 07 Jan 2026
Here's Why You Should Add NVST Stock to Your Portfolio Right Now - Eastern Progress
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Equipment & Services
|
|
| Shares Out | 164 (M) |
| Shares Float | 164 (M) |
| Held by Insiders | 0.4 (%) |
| Held by Institutions | 116.5 (%) |
| Shares Short | 9,760 (K) |
| Shares Short P.Month | 10,760 (K) |
| EPS | 0.09 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 18.71 |
| Profit Margin | 0.5 % |
| Operating Margin | 9.6 % |
| Return on Assets (ttm) | 2.6 % |
| Return on Equity (ttm) | 0.5 % |
| Qtrly Rev. Growth | 11.5 % |
| Gross Profit (p.s.) | 8.93 |
| Sales Per Share | 15.93 |
| EBITDA (p.s.) | 2.14 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 300 (M) |
| Levered Free Cash Flow | 304 (M) |
| PE Ratio | 280.44 |
| PEG Ratio | 0 |
| Price to Book value | 1.34 |
| Price to Sales | 1.58 |
| Price to Cash Flow | 13.82 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|